These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36523987)

  • 21. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
    Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
    Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma.
    Zhang L; Luo Y; Cheng T; Chen J; Yang H; Wen X; Jiang Z; Li H; Pan C
    Pharmgenomics Pers Med; 2021; 14():1549-1563. PubMed ID: 34876833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
    Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
    Front Oncol; 2021; 11():631803. PubMed ID: 33718213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
    Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
    [No Abstract]   [Full Text] [Related]  

  • 31. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
    Weng C; Wang L; Liu G; Guan M; Lu L
    Front Oncol; 2021; 11():763027. PubMed ID: 34868980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients.
    Li Z; Liu Y; Yi H; Cai T; Wei Y
    Front Genet; 2022; 13():947747. PubMed ID: 36246627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.
    Li Z; Ma Z; Xue H; Shen R; Qin K; Zhang Y; Zheng X; Zhang G
    Front Genet; 2022; 13():917150. PubMed ID: 35873497
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of m
    Zhang X; Wang C; Liu Z; Si Y
    Front Genet; 2022; 13():1011716. PubMed ID: 36226190
    [No Abstract]   [Full Text] [Related]  

  • 39. Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs.
    Zeng H; Xu Y; Xu S; Jin L; Shen Y; Rajan KC; Bhandari A; Xia E
    Front Cell Dev Biol; 2021; 9():698388. PubMed ID: 34490250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.